 Candida Aspergillus infections immunocompromised patients overview Infection major cause morbidity mortality granulocytopenic patients use aggressive chemotherapy granulocytopenia patients cancer risk disseminated fungal infection Candida Aspergillus species common fungal pathogens responsible disseminated infection diagnosis infection difficult use empiric amphotericin disseminated candida infection morbidity fungal pathogen agent choice candida infection fluconazole shows addition flucytosine efficacy amphotericin Candida infection difficult Early recognition invasive aspergillosis use high-dose amphotericin mg/ kg.d combination flucytosine mortality active toxic antifungal agents efficacy treatment prophylaxis disseminated fungal infection